- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01565057
Gastric Layering Study
May 4, 2012 updated by: Alan Mackie, Quadram Institute Bioscience
A Study on the Effect of Gastric Layering and Emptying Induced by a Food Emulsion
This comparative study is designed to compare the gastric layering and rates of emptying and by inference rates of digestion of two food emulsions.
Two types of dairy based foods will be used, one which will sediment in the stomach and one that will not.
On each of two study days, a total of 9 post drink MRI scans will be taken to assess gastric layering and emptying.
Cannulation will allow blood samples to be taken periodically for subsequent analysis for the presence of specific digestion related hormones.
A total volume of 36 ml of blood will be removed and volunteers will also be asked to complete a questionnaire at predetermined times to assess feelings of satiation.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Norfolk
-
Norwich, Norfolk, United Kingdom, NR4 7UA
- Institute of Food Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male (hormonal status of women would introduce more variation within small group)
- Age 20-50y
- BMI 19-30
- Apparently healthy
- Normally eat lunch
- Willing to eat the finely grated cheese meal
- Provide written informed consent
Exclusion Criteria:
- Individuals with an intolerance or allergy to any of the constituents of the test meal
- Smokers or smoked within the last year (smoking affects satiety/hunger)
- Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease
- Have had surgery on the stomach or intestine or suffered from gastrointestinal disease, whether diagnosed or self reported
- Regular (more than once in 10 days) use of antacids, laxatives
- Any problems with swallowing
- Take prescription medication for digestive or gastrointestinal conditions.
- Volunteers taking part in another study (other than a questionnaire based study).
- Blood pressure greater than 160/100 or less than 90/50 or 95/55 if symptomatic.
- Individuals with special dietary requirements (eg vegetarians)
- If attended a study during the previous four months where combined blood sampling from previous study and present study would exceed 470mL.
- If any of the clinical screening results are indicative of a health problem which would affect the volunteers well-being or which would affect the study data.
- Refusal to give permission to inform GP of participation in study
- Recent unexplained weight gain or loss
- History of back problems or any other condition which limit ability to repeatedly sit up and lie down
- Hiatus Hernia
MRI scanning specific exclusion criteria
- Cardiac pacemaker or artificial heart valve
- Any surgery in the last 6 months
- Aneurysm clips (metal clips from surgery)
- Implant, pump or any medical device in the body (eg cochlear implant, neurostimulator, intra-venticular shunt)
- Worked with metals (using lathes or grinders) or sustained injury to eyes involving metal splinters or fillings
- Have artificial eyes or limbs
- Have been injured with shrapnel or bullets
- Suffer from fits, blackouts or epilepsy
- Claustrophobia sufferer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: sedimenting meal
To assess whether rates of gastric emptying of a specifically formulated emulsion drink are significantly different from a control drink and that this in turn leads to differences in satiation (cessation in the desire to eat) and satiety (desire to limit further food intake) as measured by visual analogue scale (VAS) satiety questionnaire and blood CCK.
|
The active system quickly forms a sedimenting layer of small particles that contain most of the caloric content of the system.
This system is made by adding finely grated cheese (particle size 0.5-2 mm) to yoghurt and consumption is followed by drinking 327 ml water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric emptying rates
Time Frame: 3 hours
|
The primary objective is to measure gastric emptying rates and layering patterns as a function of time in healthy volunteers using two different meals, one which sediments gastric digestion and one in which it does not.
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fullness and satiety from visual analogue scores
Time Frame: 3.5 hours
|
To correlate gastric emptying rates with satiety responses after the meal
|
3.5 hours
|
|
levels of CCK in the blood
Time Frame: 3.5 hours
|
To correlate gastric emptying rates with levels of the GI hormone CCK in blood
|
3.5 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Alan R Mackie, PhD, Quadram Institute Bioscience
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
March 23, 2012
First Submitted That Met QC Criteria
March 26, 2012
First Posted (Estimate)
March 28, 2012
Study Record Updates
Last Update Posted (Estimate)
May 7, 2012
Last Update Submitted That Met QC Criteria
May 4, 2012
Last Verified
May 1, 2012
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
Clinical Trials on sedimenting meal
-
University of CopenhagenCompletedBiomarkers of Food Intake in Healthy Subjects
-
Swiss Distance University of Applied SciencesSwiss Federal Institute of TechnologyRecruitingIron Deficiency (Without Anemia)Switzerland
-
Texas A&M UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingGlucose Metabolism | Amino Acid MetabolismUnited States
-
Ryerson UniversityCompletedObesity | OverweightCanada
-
USDA, Western Human Nutrition Research CenterTerminatedObesity | Overweight | Body WeightUnited States
-
Quadram Institute BioscienceUnilever R&D; Clinical Research and Trials Unit (Norfolk & Norwich University...Completed
-
Clinical Nutrition Research Center, Illinois Institute...CompletedGlycemic ResponseUnited States
-
National Taiwan Normal UniversityCompletedBlood Pressure | Glucose ResponseTaiwan
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland